Multivariable analysis of the median hospital length of stay for cases in the late period showed that the use of Peg-G-CSF, R-CHOP dose reduction, and treatment in cancer-designated hospitals were independently associated with a reduction in the length of stay of at least 1 day. This evidence concerns the gene CSF3 and cancer.